Correlation Between Neoleukin Therapeutics and Satsuma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Satsuma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Satsuma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Satsuma Pharmaceuticals, you can compare the effects of market volatilities on Neoleukin Therapeutics and Satsuma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Satsuma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Satsuma Pharmaceuticals.
Diversification Opportunities for Neoleukin Therapeutics and Satsuma Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neoleukin and Satsuma is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Satsuma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Satsuma Pharmaceuticals and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Satsuma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Satsuma Pharmaceuticals has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Satsuma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neoleukin Therapeutics and Satsuma Pharmaceuticals
Given the investment horizon of 90 days Neoleukin Therapeutics is expected to generate 2.48 times less return on investment than Satsuma Pharmaceuticals. But when comparing it to its historical volatility, Neoleukin Therapeutics is 1.47 times less risky than Satsuma Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Satsuma Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 86.00 in Satsuma Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 24.00 from holding Satsuma Pharmaceuticals or generate 27.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 72.32% |
| Values | Daily Returns |
Neoleukin Therapeutics vs. Satsuma Pharmaceuticals
Performance |
| Timeline |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Satsuma Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neoleukin Therapeutics and Satsuma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neoleukin Therapeutics and Satsuma Pharmaceuticals
The main advantage of trading using opposite Neoleukin Therapeutics and Satsuma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Satsuma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satsuma Pharmaceuticals will offset losses from the drop in Satsuma Pharmaceuticals' long position.| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
| Satsuma Pharmaceuticals vs. Erasca Inc | Satsuma Pharmaceuticals vs. Forte Biosciences | Satsuma Pharmaceuticals vs. SAB Biotherapeutics | Satsuma Pharmaceuticals vs. Senti Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |